Publisher's Synopsis
Drugs in Context is an independent, peer reviewed and practice orientated review of all the significant data on a specific drug, placed in the context of the disease and clinical practice setting. Zolmitriptan; Editorial: "Population-based studies have demonstrated that migraine is under-diagnosed and under-treated by physicians. As a consequence, patients, although being remarkably disabled by migraine attacks, often rely on inadequate over-the-counter treatments." Disease Overview: "Migraine is a common disorder which has a profound effect on the quality of life of those who are affected, being ranked as one of the most disabling chronic disorders by the World Health Organization." Drug Review: "Zolmitriptan displays sustained efficacy over the longer-term thereby offering migraine patients consistent relief from their symptoms." Improving Practice: "The formulation of a patient management plan can assist doctors in the diagnosis and management of migraine. The key steps of such a strategy are to establish an accurate diagnosis and to educate patients about the underlying causes and treatment options for migraine."
